Schonfeld Strategic Advisors LLC - CEREVEL THERAPEUTICS HLDNG I ownership

Back to all holdings Add to watchlist

CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 86 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q2 2023$2,110,537
+334.5%
66,390
+331.1%
0.02%
+350.0%
Q4 2022$485,716
+75.3%
15,400
+80.2%
0.00%
+33.3%
Q4 2021$277,000
+55.6%
8,546
-34.3%
0.00%
+50.0%
Q1 2021$178,000–13,002–0.00%–
 Download
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q2 2021
NameSharesValueWeighting ↓
Anchor Investment Management, LLC 100$4,2400.00%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders